IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Primary Central Nervous System Lymphoma
Related studies linked through entity extraction aliases.
BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years
- Status
- UNKNOWN
- Phase
- NA
Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)
- Status
- UNKNOWN
- Phase
- PHASE2
PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute
- Status
- RECRUITING
- Phase
- N/A
MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1